
The market has also been segmented
geographically into four regions namely North America, Europe, Asia-Pacific,
and Rest of the World (RoW). Market size and forecast has been provided for
each of these regions. A detailed qualitative analysis of the factors
responsible for driving and restraining the growth of the epigenetics market
and future opportunities are provided in the report.
To Read The Complete Report with TOC: http://www.marketresearchreports.biz/
Competitive landscape and end user
analysis for the product types is highlighted and the market players are
profiled with attributes such as company overview, financial overview, business
strategies, product portfolio and recent developments. Market shares of the key
players for 2011 are provided, and recommendations to accentuate market shares
and ensure sustainability are also put forward in this report. Key market
player profiles in this report include Celgene Corporation, Eisai
Pharmaceuticals, Pharmacyclics Inc., Merck & Co. Inc. and others.
The global epigenetics drugs and
diagnostic technologies market is segmented into the following categories:
- Epigenetics Drugs Market, by
Mechanism of Action
- DNMT Inhibitors
- Azacitidine (Vidaza)
- Decitabine (Dacogen
- HDAC Inhibitors
- Vorinostat (Zolinza
- Romidepsin (Istodax)
- Epigenetics Diagnostic
Technologies Market, by Types
- DNA Methylation
- Chromatin Immunoprecipitation
(ChIP) Technology
- Epigenetics Technologies
Market, by Geography
- North America
- Europe
- Asia-Pacific
Contact
M/s Sheela
90 Sate Street, Suite 700
Albany, NY 12207
Tel: +1-518-618-1030
USA – Canada Toll Free: 866-997-4948
No comments:
Post a Comment